HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER

被引：0
|
作者：
HEDLEY, D [1 ]
DALGLEISH, A [1 ]
COATES, A [1 ]
FOX, R [1 ]
RAGHAVAN, D [1 ]
TATTERSALL, M [1 ]
机构：
[1] LUDWIG INST CANC RES,SYDNEY CANC THERAPY BRANCH,SYDNEY,AUSTRALIA
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1983年 / 11卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [21] HIGH-DOSE VERSUS LOW-DOSE MEDROXYPROGESTERONE ACETATE - A RANDOMIZED TRIAL IN ADVANCED BREAST-CANCER
    GALLAGHER, CJ
    CAIRNDUFF, F
    SMITH, IE
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (12): : 1895 - 1900
  • [22] THE PHARMACOKINETICS OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN THE THERAPY OF METASTATIC BREAST-CANCER
    BLOSSEY, HC
    BARTSCH, HH
    KOEBBERLING, J
    NAGEL, GA
    ACTA ENDOCRINOLOGICA, 1981, 97 : 207 - 207
  • [23] STEROID-HORMONE RECEPTORS AND RESPONSE TO HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER
    NOMURA, Y
    TASHIRO, H
    HISAMATSU, K
    SHINOZUKA, K
    ANTICANCER RESEARCH, 1988, 8 (04) : 647 - 652
  • [24] ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE VERSUS TAMOXIFEN - A RANDOMIZED CROSSOVER TRIAL IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER
    VANVEELEN, H
    WILLEMSE, PHB
    TJABBES, T
    SCHWEITZER, MJH
    SLEIJFER, DT
    CANCER, 1986, 58 (01) : 7 - 13
  • [25] A PHASE-III TRIAL OF ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) VERSUS MEPITIOSTANE IN ADVANCED POSTMENOPAUSAL BREAST-CANCER
    IZUO, M
    YOSHIDA, M
    TOMINAGA, T
    ABE, O
    ENOMOTO, K
    NOMURA, Y
    KUBO, K
    TAKATANI, O
    CANCER, 1985, 56 (11) : 2576 - 2579
  • [26] 5-FLUOROURACIL, ADRIAMYCIN AND CYCLOPHOSPHAMIDE COMBINED WITH HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER
    LOPEZ, M
    DILAURO, L
    PERNO, CF
    PAPALDO, P
    BARDUAGNI, M
    BARDUAGNI, A
    TUMORI, 1983, 69 (06) : 545 - 551
  • [27] MECHANISM OF ADRENAL SUPPRESSION BY HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER PATIENTS
    VANVEELEN, H
    WILLEMSE, PHB
    SLEIJFER, DT
    VANDERPLOEG, E
    SLUITER, WJ
    DOORENBOS, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (02) : 167 - 170
  • [28] CHEMOTHERAPY WITH OR WITHOUT HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ESTROGEN-RECEPTOR-NEGATIVE ADVANCED BREAST-CANCER
    GUNDERSEN, S
    KVINNSLAND, S
    KLEPP, O
    LUND, E
    HANNISDAL, E
    HOST, H
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) : 390 - 394
  • [29] HIGH-DOSE MEDROXYPROGESTERONE ACETATE PLUS MITOMYCIN-C OR VINDESINE IN THE TREATMENT OF ADVANCED BREAST-CANCER
    FALKSON, CI
    FALKSON, HC
    FALKSON, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (04): : 431 - 434
  • [30] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER RESISTANT TO ENDOCRINE AND CYTOTOXIC THERAPY
    DELENA, M
    BRAMBILLA, C
    VALAGUSSA, P
    BONADONNA, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1979, 2 (03) : 175 - 180
12345